November 25, 2019 11:20 AM ESTUpdated 11:35 AM

Shares of Adamis crater on CRL; Boris Johnson promises to double dementia research funding

Kathy Wong

Editor

→ San Diego-based Adamis $ADMP saw its shares crater on the news that the FDA has rejected its application to market high-dose naloxone injection …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Shares of Adamis crater on CRL; Boris Johnson promises to double dementia research funding

Kathy Wong

Editor

Sign up to read this article for free.

‭ Regulatory Lead / Head of Regulatory‬

Autonomy Bio Inc.

San Francisco, CA 94107, USA

Updated: Patient dies in Rocket gene therapy trial, which is put on clinical hold by FDA

Lilly to buy non-opioid pain biotech SiteOne for up to $1B

RFK Jr. ends annual Covid vaccine recommendations for kids, pregnant women

Biogen taps City Therapeutics in RNAi deal worth up to $1B

Investors pump $130M into protein degrader startup GlycoEra

From weeks to days: how Aizon Intelligent Agents transform pharma validation

Shares of Adamis crater on CRL; Boris John­son promis­es to dou­ble de­men­tia re­search fund­ing

Editor

Sign up to read this article for free.

Autonomy Bio Inc.

San Francisco, CA 94107, USA

Shares of Adamis crater on CRL; Boris Johnson promises to double dementia research funding